tiprankstipranks
Advertisement
Advertisement

EKF Diagnostics Buys Back 100,000 Shares, Updates Voting Capital

Story Highlights
  • EKF Diagnostics repurchased 100,000 shares at 23.6p to hold in treasury, adjusting its capital structure and voting share count.
  • The buyback slightly reduces free float and may support valuation, while major holder Harwood Capital’s position remains unchanged.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
EKF Diagnostics Buys Back 100,000 Shares, Updates Voting Capital

Claim 55% Off TipRanks

EKF Diagnostics Holdings ( (GB:EKF) ) has provided an announcement.

EKF Diagnostics Holdings has repurchased 100,000 of its ordinary shares at a weighted average price of 23.6 pence per share, with the stock to be held in treasury rather than cancelled. The transaction signals ongoing use of its buyback authority and leaves the company’s total issued share capital at 431,963,112 shares, of which 430,998,112 now carry voting rights, a key reference point for investors monitoring disclosure thresholds.

The buyback modestly reduces the free float and may support the share price by demonstrating management’s willingness to return capital and manage equity efficiently. Harwood Capital Management did not participate in this particular transaction, indicating no change in holdings for that significant shareholder, while the updated voting share count provides clarity for stakeholders tracking ownership changes under FCA transparency rules.

The most recent analyst rating on (GB:EKF) stock is a Hold with a £26.00 price target. To see the full list of analyst forecasts on EKF Diagnostics Holdings stock, see the GB:EKF Stock Forecast page.

Spark’s Take on EKF Stock

According to Spark, TipRanks’ AI Analyst, EKF is a Neutral.

The score is driven by solid financial resilience (low leverage and generally healthy cash generation) and a constructive earnings outlook (margin improvement, capacity expansion, new contracts, and buyback). These positives are tempered by weak technicals (price below major moving averages and negative MACD) and only mid-range valuation support (P/E ~15.6, no dividend yield provided).

To see Spark’s full report on EKF stock, click here.

More about EKF Diagnostics Holdings

EKF Diagnostics Holdings is an AIM-listed global diagnostics business specialising in point-of-care analysers in hematology and diabetes, as well as life sciences services that manufacture enzymes and custom products for diagnostic, food and industrial uses. Headquartered in Penarth near Cardiff, the company operates five manufacturing sites in the U.S. and Germany and sells into more than 120 countries worldwide.

Average Trading Volume: 354,589

Technical Sentiment Signal: Strong Sell

Current Market Cap: £101.7M

See more insights into EKF stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1